GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biodyne Co Ltd (XKRX:314930) » Definitions » Equity-to-Asset

Biodyne Co (XKRX:314930) Equity-to-Asset : 0.98 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biodyne Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biodyne Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩42,986 Mil. Biodyne Co's Total Assets for the quarter that ended in Mar. 2024 was ₩43,767 Mil. Therefore, Biodyne Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.98.

The historical rank and industry rank for Biodyne Co's Equity-to-Asset or its related term are showing as below:

XKRX:314930' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.28   Med: 0.84   Max: 0.99
Current: 0.98

During the past 7 years, the highest Equity to Asset Ratio of Biodyne Co was 0.99. The lowest was 0.28. And the median was 0.84.

XKRX:314930's Equity-to-Asset is ranked better than
99.88% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs XKRX:314930: 0.98

Biodyne Co Equity-to-Asset Historical Data

The historical data trend for Biodyne Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodyne Co Equity-to-Asset Chart

Biodyne Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.28 0.28 0.84 0.97 0.99

Biodyne Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.99 0.99 0.99 0.98

Competitive Comparison of Biodyne Co's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Biodyne Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biodyne Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biodyne Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biodyne Co's Equity-to-Asset falls into.



Biodyne Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biodyne Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=43382.133/43986.039
=0.99

Biodyne Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=42985.908/43766.866
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biodyne Co  (XKRX:314930) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biodyne Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biodyne Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biodyne Co (XKRX:314930) Business Description

Traded in Other Exchanges
N/A
Address
24-4, Achasan-ro 5-gil, Seongdong-gu, Seoul, KOR, 04793
Biodyne Co Ltd develops and produces pathplorer LBC system, test equipment and reagents for cancer diagnosis.

Biodyne Co (XKRX:314930) Headlines

No Headlines